# CLOBETASOL PROPIONATE
> **ANDA210034** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2018-06-15
## Drug
- **FDA Application Number:** ANDA210034
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CLOBETASOL PROPIONATE
- **Generic name:** CLOBETASOL PROPIONATE
- **Active ingredients:** CLOBETASOL PROPIONATE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** Xiromed, LLC
- **First approval:** 2018-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210034)
---
*MORVS · CC0 1.0*